The approval of the Intact's peripheral artery dissection repair device is based on results from the 213-patient TOBA II trial, which showed Tack resolved 92.1% of dissections in peripheral arteries following balloon angioplasty.
• Source: Intact Vascular
[Editor's note: Complete historical data on global device approvals can be found in Medtech Insight's Approvals Tracker and at MedDeviceTracker].
The US FDA approvedIntact Vascular Inc.’s Tack endovascular device to repair arterial dissections following percutaneous transluminal balloon angioplasty...
